Press-release for stocks for TEVJF

symbols : TEVJF

save search

Spinal Cord Injury Therapeutics Market surpass $10.7 billion by 2031 - Exclusive Report by Coherent Market Insights
Published: 2024-01-31 (Crawled : 16:00) - prnewswire.com
RSPI | $0.0009 0.0% 1.2M

Manufacturing

| -47.37% | O: -5.26% H: 27.78% C: 5.56%
report therapeutics market

Alvotech to Report First Six Months and Second Quarter 2022 Financial Results on August 31, 2022 and Host Business Update Conference Call at 8:00 am ET on September 1, 2022
Published: 2022-08-15 (Crawled : 09:00) - biospace.com/
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 75.62% | O: -0.78% H: 19.48% C: 19.48%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| -2.08% | O: 0.38% H: 2.07% C: 2.07%
conference report six update results

2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published: 2024-01-17 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

Health Technology

| -10.45% | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| -9.15% | O: -0.78% H: 0.59% C: 0.57%
VRNA | $15.21 -2.44% -2.5% 320K

Health Technology

| -8.87% | O: 0.52% H: 2.31% C: -0.87%
NKTR | News | $1.39 -2.11% -2.16% 960K

Health Technology

| 179.58% | O: -0.73% H: 12.24% C: 12.24%
companies report pipeline research key

Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Published: 2024-01-19 (Crawled : 17:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 10.4% | O: 6.64% H: 11.54% C: 8.1%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| -11.73% | O: -0.85% H: 1.46% C: 0.69%
avt02 avt04 license update

Alvotech to Participate in Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 09:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 65.73% | O: -3.06% H: 8.59% C: 6.44%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 4.22% | O: -0.92% H: 0.0% C: -2.11%
conference

Alvotech to Participate in 2023 Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 11:00) - biospace.com/
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 65.73% | O: -3.06% H: 8.59% C: 6.44%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 4.22% | O: -0.92% H: 0.0% C: -2.11%
conference

Teva Reports Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
TEVA | $13.01 -0.68% 7.5M

Health Technology

| 56.94% | O: 5.55% H: 8.46% C: 5.71%
teva financial results

Anti-obesity Drugs Market Size to Grow by USD 454.51 million | Growing Obese Population to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-07-06 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -23.06% | O: -0.73% H: 1.02% C: 1.02%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -24.51% | O: -0.51% H: 0.73% C: 0.07%
BHC | $8.56 0.35% 0.0% 2M

Health Technology

| -5.41% | O: -0.77% H: 1.61% C: -4.45%
RYTM 4 | $39.71 -0.73% -0.73% 400K

Health Technology

| 802.5% | O: 0.45% H: 8.37% C: 7.24%
research growing growth market obesity

Autologous Cell Therapy Market Size to Grow by USD 4.11 billion, Bayer AG and Brainstorm Cell Therapeutics Inc. Among Key Vendors - Technavio
Published: 2022-08-01 (Crawled : 11:00) - prnewswire.com
BCLI A | $0.5339 1.7% 1.67% 190K

Health Technology

| -78.52% | O: 0.78% H: 7.95% C: 5.43%
therapeutics therapy market

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate
Published: 2023-01-13 (Crawled : 10:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 12.83% | O: 0.42% H: 7.8% C: 4.56%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 2.17% | O: -0.59% H: 0.79% C: 0.59%
partnership pharma candidate biosimilar

Uveitis Drugs Market, High Prevalence Of Eye Disorders And Associated Risk Factors Of Uveitis to Boost Market Growth - Technavio
Published: 2022-08-08 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| 14.44% | O: 1.28% H: 0.8% C: 0.13%
BHC | $8.56 0.35% 0.0% 2M

Health Technology

| 46.58% | O: -7.02% H: 7.55% C: -4.6%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 19.57% | O: 0.24% H: 1.11% C: -0.31%
BIIB | $201.91 4.52% 4.32% 3.3M

Health Technology

| -7.16% | O: -0.56% H: 1.04% C: 0.58%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 10.4% | O: -0.03% H: 1.02% C: 0.47%
risk eye growth market

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 4.96% | O: 1.16% H: 7.28% C: 1.3%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 1.76% | O: 1.76% H: 0.0% C: 0.0%
humira biosimilar approved for agreement

Alvotech Shares Start Trading on Nasdaq Iceland Main Market
Published: 2022-12-08 (Crawled : 09:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 81.02% | O: 1.6% H: 7.24% C: 5.26%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 13.57% | O: -0.44% H: 3.3% C: 3.3%
nasdaq market

STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
Published: 2023-11-10 (Crawled : 14:30) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 55.81% | O: 0.12% H: 7.18% C: 3.56%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 11.61% | O: -0.22% H: 0.86% C: 0.86%
biosimilar chmp positive stelara

Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
Published: 2022-10-17 (Crawled : 10:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

n/a

| 99.71% | O: 0.44% H: 7.05% C: 2.64%
KMDA | $5.16 1.18% 1.16% 11K

Health Technology

| 18.49% | O: 2.74% H: 0.89% C: 0.0%
candidate biosimilar japan application approval

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
Published: 2023-01-04 (Crawled : 12:00) - ir.biolinerx.com
BLRX | $0.5966 -6.31% -6.74% 760K

Health Technology

| -6.15% | O: 0.66% H: 6.97% C: 6.02%
medical